Добавил:
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Применение углеродных нанотрубок в биомедицине 2 / Polizu, S., Savadogo, O., Poulin, P., & Yahia, L. (2006). Applications of Carbon Nanotubes-Based Biomaterials in Biomedical Nanotechnology. Journal of Nanoscience and Nanotechnology, 6(7), 1883–1904. doi10.1166jnn.2006.197

.pdf
Скачиваний:
18
Добавлен:
01.03.2023
Размер:
338.16 Кб
Скачать
J. Nanosci. Nanotechnol. 6, 1883–1904, 2006

Polizu et al.

Applications of Carbon Nanotubes-Based Biomaterials in Biomedical Nanotechnology

 

 

5. BIOMEDICAL APPLICATIONS OF

sheet dimension, with a minimum length corresponding to

CARBON NANOTUBES

 

0.5 V was observed. In fact, the mechanism for convert-

5.1. CNTs Smart Materials

 

ing electrical energy into mechanical energy is based on

 

the double-layer charge injection and it involves the inter-

 

 

5.1.1. Artificial Muscles and Actuators

 

face nanotubes-solution.137 139 The actuation is due to a

 

geometrical expansion of the C–C covalent bonds caused

 

 

An artificial muscle analogous to a biological muscle is

by charge injection and originates from quantum chemical

composed of an actuator material that must be able to

and double layer electrostatic effect.140 Such response,

work in a specific way in order to successfully mimic

devoid of an ionic contribution, eliminates the disadvan-

the natural one. The natural muscles are distinguished by

tages related to the faradaic conducting polymer actuators,

some characteristics: anisotropic behaviour consisting in

for which the life cycle, the discharge rate, and the energy

contraction-elongation along the fiber axis, high energy

conversion efficiency are limiting parameters.141 This new

density, fast speed and response, as well as large stroke.

mechanism is sustained by structural model of SWNT, its

With a maximum power output of 150–225 w/Kg, they can

electrical conductivity along with mechanical and charge

withstand a stress up to 150–300 KPa. The work of mus-

transfer properties.138 Since this assertion, the non-faradaic

cles is defined by three variables: the stress which they can

actuation concept has been predicted by theoretical studies

exert, the strain by which they can be shortened and the

and experimentally demonstrated using both individual and

contraction frequency.135 Actuation capacity consists in the

ropes SWNTs as well as the MWNTs.140 The first isomet-

ability to efficiently convert electrical energy into mechan-

ric measurements shows high values for elastic modulus,

ical movement and its requirements are defined in terms

of 1–2 GPa, and maximum deformation of 0.2%, corre-

of stroke and force. Generally, an actuator is composed

sponding to a stress equal to 0.75 MPa. In fact, individual

of at least three elements: two electrodes whose function

nanotubes display much better mechanical and electronic

is to apply the potential, and an interposed element.136

properties, expressed by a stress of 1 000 GPa and 1%

The ideal actuating material would operate at low voltage

actuation strain. It has been demonstrated that the struc-

and at match least performance of skeletal muscle:137 10%

tural deformation as well as the conversion of electrical

strain, 0.3% MPa stress generated and 10% s−1 strain rate.

energy into mechanical force, through radial and longitu-

Characteristics such as light, low-volume, long cycle-life,

dinal expansion or contraction, are more due to the elec-

Delivered by Publishing Technology to: University of Waterloo

large displacement, and high forcesIP:are200required.59.59.16forOn:actuTue,-

tronic structure than to the coulomb interactions. Since,

20 Oct 2015 13:16:49

 

138

 

Copyright: American Scientificseveral worksPublishweres performed attempting to explain the

ator design and some of them correspond to CNTs.

 

actuation performance of nanotubes and hence improve

The nanotube’s actuation behaviour is generated by its

good electronic and mechanical properties coupled with

these characteristics.141 They principally focus on both the

a high surface area as well as a non-faradaic nature of

fabrication and manipulation of CNTs in order to obtain

the electrochemical response. Owing to these properties,

suspended nanotubes.140 By manipulating these nanotubes

the nanotube actuators perform high strain per movement

with AFM tip, and examining the change in cantilever

and generate greater mechanical stress than any other

deflection, the measurements of both the Young’s modulus,

materials,139 when a current of a few volts is applied. In

and actuation force are easily performed.140 142–144 More-

this type of actuator, the nanotube acts as an active material

over, Frayse and his collaborators144 studied nanotubes

and constitutes one of the electrodes which are immersed in

obtained by CVD growth and deposited on trenched quartz

an electrolytic solution or solid polymer electrolyte.138 139

substrate with the NT’s ends fixed. They thus estimated

Theoretical predictions and experimental measurements

the actuation capability under bias voltage in an electro-

have suggested that actuators using carbon nanotubes allow

chemical cell by measuring the deformation of nanotubes

high performances consisting in higher work densities by

with AFM cantilever.140 According to the hypothesis that a

cycle138 and have significant contribution in term of time

limited macroscopic response arises from the building and

and speed as well as reproducibility of its response.

 

entanglement of individual nanotubes at mesoand macro-

 

 

scopic scale, the authors found the possibility of taking

5.1.2. CNTs Actuators for Artificial Muscles

 

measurements at individual nanotube level. In the same

 

prospect, Roth and Baughman experimented with individ-

In 1999138 Baughman has demonstrated, for the first time,

ual nanotubes as actuators and demonstrated that the nano-

that carbon nanotubes can act as an actuator thus proposing

objects change their shape when electrically charged.145

the first prototype for a bimorph actuator. The macroscopic

Since the purification level of nanotube was identified

sheets, so called buckypapers, consisting of randomly

as a concern for the efficiency of the actuation pro-

entangled SWNT bundles act like working electrodes,

cess, cumulated efforts contributed to the development of

connected to a potentiostat in electrochemical cells. An

highly purified, aligned CNT, with high surface area.112–114

axial strain of up to 0.2% was provided by using buky-

Moreover, significant improvement of actuation strain

paper while switching the electrochemical potential from

rate was achieved by operating carbon nanotubes in an

0.5 V to −1 0 V A roughly parabolic dependence of

organic electrolyte.146 147 For instance, the use of resistance

1893

Applications of Carbon Nanotubes-Based Biomaterials in Biomedical Nanotechnology

Polizu et al.

 

 

compensation resulted in a higher rate, of 0.6% s−1

addition reaction on nanotube external surfaces and its sol-

[148] with an increasing pulse amplitude and more nega-

ubilisation in aqueous media. At the same time, an exhaus-

tive potential limit. Thus, a strain amplitude of 0.3%

tive work on solubilization of SWNT has been directed

in 0.5 s was attained which is considerably better than

towards the assembly of coated peptides.119

 

0.5% in 1 s, previously reported. Despite a small dis-

Nanotube-based supramolecular structures have been

placement of nanotubes, these results sustain the unde-

prepared by controlling the factors that influence peptide-

niable actuation capacity of advanced carbon nanotube

peptide interactions.159 Based on both molecular modeling

structure and forecast their promising potential149 for actu-

and experimental data, an amphiphilic -helical peptide

ators with a performance similar, in some respects, to that

model was developed with the aim to predict the self

of a biological muscle. This CNTs resource to emulate

assembly function. This construction is the first step

artificial muscles opens the door for nanoscale devices150

towards a new architectural arranging of carbon nanotubes

with various applications. Other actuating designs, such

for molecular sensing mechanisms. Thus, a recent identi-

implants for tissue stimulation151 152 or electrical stimula-

fication of polypeptides with selectivity for nanotubes160

tor capable of encouraging ostoeogenezis are envisaged.153

announces a new method for the manipulation and use of

In combination with biopolymers, such as collagen,154 or

CNTs in the biological and medical area. These peptide

functionalized,155 carbon nanotubes are processed as mate-

sequences, with specific affinity for nanotubes, naturally

rial for the creation of engineered tissue or as component

bind to the surface of carbon nanotubes, in a selective man-

for other devises. Although our focus is not the presen-

ner; this ability is owed to the flexibility and conformation

tation of carbon nanotubes as macroscopic material, we

of their chains. It seems that peptidic chains act as symmet-

mention that, the advantages coming from this avenue are

ric detergents, with hydrophobic sequence in the middle

very enriching for the design of biocompatible biomateri-

and hydrophilic ones at the ends. Their inherent selectivity

als. Indeed it has been proven that the insertion of func-

enables them to discriminate between different nanotube

tionalized CNTs in a collagen scaffold induce positive

structures, according to their chirality and diameter, and

effects155 in terms of physiology, electrical conductivity,

thus facilitates the CNTs manipulation for biosensors.

and mechanical behaviour.

The multifunctionalization of CNTs finds application in

With regard to the macroscopic formulation of the

the design of systems for delivery of antibiotics to different

CNTs, it is important to note that composite structure is

type of cells. Using selective transport through the mem-

Delivered by Publishing Technology to: University of Waterloo

 

another alternative of material whichIP: 200could.59improve.59.16 On:actu-Tue,brane,20 Octa 2015new approach13:16:49is proposed for the modulation of

ator performance. In this context SWNT-Nafion composite

the therapeutic actions.

 

Such strategy was experimented

Copyright: Amer can Sci ntific Publishers

161

 

actuators were created and tested.156 The results qualify the

in the last year and demonstrated, in vitro, the aptitude

system as promising potential for MEMS switches con-

of oxidized MWNTs to conjugate with both fluorescin

struction. Moreover, combinatory actuator effect of both

and amphotericin (AmB) molecules. Even though AmB is

carbon nanotubes and conductor polymer, such as polyani-

known to be the most effective antibiotic for cronical fun-

line, are in exploration.157 Film composites were tested in

gal infection, a high toxicity risk appears when in contact

order to evaluate the actuation synergism of two compo-

with mammalian cells. Consequently, the advantage of this

nents in a new actuator material. The influence of elec-

new conjugated system consists in its capacity to partially

trolyte has also been evaluated by using both salt and basic

avoid the molecules aggregation resulting in more aque-

solutions. Thus, the contribution of redox process was evi-

ous solubility for AmB and internationalization capacity

denced while demonstrating the increase in conductivity

of CNTs, which finally improve antibiotic activity.

of composite by participation of CNTs, leading to more

The influence of interfacing of carbon nanotubes with

electrochemical efficiency. It is more evident that mate-

biomolecules is various162 and could be extended to certain

rial processing offers a diversification of smart materials

reactions which they influence. Indeed, an investigation of

for actuators. Indeed, the experimental work on nanotube-

effects generated by addition of SWNT to the polymerase

epoxy layered actuator is promising for the development of

chain reaction163 illustrate an increase in efficiency of poly-

dry nanocomposites actuator material.158 In spite of man-

merase mechanism, proving the capacity of nanotubes to

ufacturing challenge, it appears that these composites may

act as catalysts in a variety of biochemical reactions as elec-

become a new smart material for structural application,

tron/donor receptors. With regards to biologic cells, carbon

which could promote the development of dry actuator, as

nanotubes showed excellent proliferation164 for cell culture.

component of active prostheses.

These effects can be accommodating for exploitation of

 

carbon nanotubes as scaffold for regenerative medicine.

5.2. Biomolecules and Carbon Nanotubes Assemblies

The first step towards the synthesis of peptides based carbon nanotubes started a few years ago with the achievement of derivatives of SWNTs and MWNTs with n-protected aminoacids.118 The method is based on the

5.3. CNT Neural Biomaterial

Neural prostheses provide the means to apply and monitor electrical signals in neural tissues. The development of systems able to restore the nerve function does not strictly

1894

J. Nanosci. Nanotechnol. 6, 1883–1904, 2006

1895

Polizu et al.

 

Applications of Carbon Nanotubes-Based Biomaterials in Biomedical Nanotechnology

 

 

lie in the realm of neuroscience, medicine and engineer-

(ii) small particle size minimizes possible irritant reactions

ing; new possibilities arise at the interface of all three and

at the injection site;

 

 

 

demand the use of advanced biomaterials. Carbon nano-

(iii) miniaturised size allows the penetration of carriers in

tubes possess excellent electrical properties which have

the membrane of the sicken cells, thus providing a way

been proven useful in the area of neural prostheses. The

to selectively deliver the drug to cancerous tumours, while

pertinence of nanotube fibers as neural prosthetic biomate-

avoiding the healthy cells.

 

 

rial has been demonstrated by McKenzie and his collabora-

As presented in the section about functionalization, well

tors.165 Thanks to their capacity to minimize the astrocites

functionalized nanotubes and their derivatives are destined

function, the CNTs possessing high surface energy become

for biomedical and biotechnological applications. Indeed,

interesting

biomaterials for a new

generation of neural

the organic modification

of nanotubes creates multiple

prosthesis. Haddon and his colleagues reported the appli-

attachment sites for bioactive molecules and hence facili-

cation of carbon nanotube in neural research and estab-

tates the assembly in complex nanodevices. A very recent

lished the

function of nanotubes as

a support for nerve

study demonstrated the capacity of nanotubes to serve as

cell growth as well as substrates for probes with neu-

vehicles for the administration of vaccines84 85

by devel-

ronal function at nanometer scale.166 Using nanotubes of

oping new and

effective

delivery

approaches

of protec-

diameters similar to those of small nerve fibers, they devel-

tive antigens. They offer the possibility to effectively use

oped methods for growing embryonic rat-brain neurons

the antigens while enhancing and modulating the immune

on MWNT. The chemically modified MWNT coated with

response. The

potential

of CNTs

to present

a biologi-

4-hydroxynonenal bioactive molecules stimulated neurite

cally important

epitope,

with the

appropriate

conforma-

growth with extensive branching. A similarity between the

tion, in vitro and in vivo tests, enables them to be used in

diameter of nanotubes, ranging from 1 nm for SWNT and

vaccine delivery. The peptide-carbon nanotube conjugated

10–100

 

nm for MWNT, and those

of neurites, favours

 

system, integrating aminoderivatized nanotubes selectively

localized molecular interactions, necessary for the forma-

bonded to a peptide, provides the peptide bis-adducts.85.

tion of a neuronal circuit. Furthermore, the conductivity

This conjugated system elicited strong anti-peptide anti-

of nanotubes renders them a valuable candidate for elec-

body response and retains the antigen conformation, which

trophysiological analysis of neuronal micro circuitry. It is

fulfills the main requirements for the induction of an anti-

known that neural development is based on a complex

 

 

 

 

 

 

 

 

Delivered by Publishing Technology to: University of Waterloo

 

 

 

 

 

 

 

body response, with the accurate specificity. Since nano-

phenomenon that requires, amongIP:others,200the.59.outgrowth59.16 On:ofTue, 20 Oct 2015 13:16:49

 

 

 

 

 

 

 

 

tubes do not have any detectable immunogeneicity, the

neurites.

167

 

Copyright: American Scientific Publishers

 

 

 

 

 

The investigation of CNTs as neural biomate-

system is very appropriate for the delivery of a vaccine

rials directly requires biocompatibility studies. Investigat-

antigen. More

specifically, new structures are designed

ing the in vitro cytocompatibility of CNTs,168 the authors

using water soluble SWNT derivatives which are able to

demonstrated the beneficial effects of carbon nanofibers

cross the cell membrane;84 they can be accumulated in the

to limit

 

astrocyte functions, leading

to a decreased glial

cytoplasm or reach the nucleus without being toxic up to

scar tissue formation and further established a relationship

a quantity/concentration of 10 pm; their investigation as

between fiber characteristics and astrocyte interactions.

delivery systems in targeting therapy171 demonstrated that

These investigations promote the development of minia-

the absence of immunogenicity of nanotubes increases the

turized devices in which the nanotubes play a role in the

efficacy of their function.

 

 

 

formation of a nerve cell network with an active func-

 

 

 

 

 

 

 

 

tion, possibly to contribute to the restoration of a damaged

5.5. Miniaturized Devices and Nanorobotics

 

neuronal

circuit. These encouraging results recommend

 

for Nanomedicine

 

 

 

CNTs as promising neural biomaterial for the innova-

 

 

 

 

 

 

 

 

tion of implant devices for the central nervous system.

5.5.1. CNTs Electrodes and Biosensors

 

Today this area is limited by the use of silicon material

CNT Electrode: Carbon nanotube is a better electrode

which shows the capacity to induce significant glial scar

tissue formation169 which is known as a common diffi-

material than the classical carbon and its development

culty in the field of neural prosthetics. Indeed very recent

becomes a relatively new topic in electrochemical stud-

results demonstrating the biocompatibility of native and

ies. The useful electrochemical properties combined with

functionalized single-walled carbon nanotubes for neural

its high surface area provide some advantage to the field.

applications170 promote the CNTs potential for regenera-

Although the CNTs inertness is evident, it has been proven

tive medicine.

 

that the chemical environment to which the nanotubes are

 

 

 

 

 

exposed influences their conducting capacity and thus cre-

5.4. CNTs for Delivery Systems

 

ates an additional transduction mechanism. It

has been

 

demonstrated that CNTs can enhance the electron transfer

 

 

 

 

 

Three characteristics of nanostructured materials recom-

when used as an electrode in electrochemical reactions.9 11

mend them for the design delivery system:

An important advantage lies in the fact that these materials

(i) nanoscale size enables intravenous injection;

are very sensitive to various molecules with the reactivity

J. Nanosci. Nanotechnol. 6, 1883–1904, 2006

These macromolecular biological compounds are properly attached to the transducer surface through immobilization processes which do not only enable the fixation of the receptor to the surface but also improve the stabilisation of biological materials. Research efforts pursued in the last few years mainly focus on the development of new techniques involving bio-nanosensors effective at the single cell level, where the detection mechanisms involve chemical interactions between nanotube surface atoms and the absorbed molecules119 175
1896

Applications of Carbon Nanotubes-Based Biomaterials in Biomedical Nanotechnology

 

 

 

 

 

Polizu et al.

 

 

controlled by the redox system. Moreover, due to its highly

CNTs provide an excellent platform for biosensors and

specific capacitance, the CNTs can be used as electro-

even for integrated systems, able to analyse the chemical

chemical devices. The well-aligned MWNTs based elec-

and biological environment. Owing to their high surface

trodes have demonstrated their successful application for

area and outstanding electrical properties, the nanotubes

the detection of uric acid in urine samples with excel-

performance is superior when compared to conventional

lent sensitivity and selectivity.172 When employed as an

materials. Experimental results clearly demonstrate that

electrode, the relationship between structure-topology and

electrical conductivity changes as the carbon nanotubes

properties enables the use of the enzyme-immobilized

are exposed to a minuscule amount of a certain gas

CNTs for biomolecular sensing or as a miniaturised sensor

molecules.10 16 Thus, SWNT based chemical sensors183

in gas environmental analysis. These chemically modified

display a dramatic change in their electrical resistance

CNTs enhance the electrode sensitivity and selectivity.173

when exposed to gaseous molecules such as N, O2, and

Therefore, using layer-by-layer methodology, the nano-

NH3.184–186 Recent achievements have confirmed the apti-

scale biosensors were constructed. These electrodes enable

tude of individual SWNTs to detect the smallest concen-

to generate an electrochemical signal as function of sub-

trations of toxic gas molecules, such as NO2 and NH3, as

strate concentration, resulting in very good detection

documented by Dai and his group.187 In fact, this molec-

limit.174

 

 

 

 

ular wire benefits from the full exposure of nanotube sur-

CNTs Biosensors: One of the most important and far

face to chemical environment, thus conducting to a fast

reaching applications of nanotubes is in the biosensors

response and sensitivity as high as 103.

 

 

 

field where their biorecognition function is combined with

Moreover, the capacity of CNTs to detect ppm-level

signal transduction. Combining biological selectivity with

compounds at room temperature allows the development

the electronic process, the biosensors provide direct infor-

of nanotube sensor at physiological temperatures because,

mation about the chemical composition of their biological

once fully immersed in water, the SWNT still maintains

environment. They constantly screen the presence, absence

its intrinsic electronic properties.

 

 

 

 

Such ability

propels nanotubes towards the design

or concentration of organic or inorganic substances with

of

miniaturized

implantable devices such

as,

biomedi-

a rapid time of response, thus allowing a continuous real

cal nanosensors with high impact on nanomedecine;187–189

time monitoring of analysts. The biosensors not only have

these nanodevices will further promote innovation in early

 

 

 

 

 

 

a stand–alone identity butDeliveredthey also actby Publishingas part of mediTechnology-

to: University of Waterloo

 

 

 

 

 

 

 

 

 

175 176

detection diagnostic techniques. More specifically, the sen-

cal

devices for the

 

IP: 200.59.59.16 On: Tue, 20 Oct 2015 13:16:49

 

 

 

 

 

detection of

toxic substances

 

 

 

 

 

 

 

 

 

 

 

 

or therapeutic drug

monitoring.

177 178Copyright: American ScsitiveentificdetectionPublishersof nanotubes-based probes in conjunction

 

Several biological

with the modulation of mechanical or electrical character-

events such as genotoxicity, immunotoxicity, biotoxin, and

istics favours the interactions with a biologic host, i.e., the

endocrine effects are measured using biosensors.179–182

The sensing process is divided in two parts: recogni-

deposited cellular materials on the surface.190–192

 

Endowed with a high specificity, these devices are dedi-

tion, which results in selectivity and amplification which

cated to accurate control performance of environment193–195

increases the power of weak signals to a level at which

and even for in vivo and in vitro evaluation.196–198 Thus,

it can be conveniently manipulated by electronic devices.

a drastically

change

in

nanotube electrical properties,

The multiplicity in transduction mechanisms and amplifi-

in

response

to

the

surrounding

environment,

is con-

cation, processing variety along with its suppleness in ele-

verted in

high

specific, sensitive

signal

as

predicted by

ments recognition create a wide range of biosensors. Five

theoretical

studies199

and

demonstrated

by

experimental

principal groups of biologically sensitive materials can be

measurements.200 201

 

 

 

 

 

 

used for selective recognition:

 

 

 

 

 

 

 

 

 

 

 

 

In fact,

the potential of nanotube as

electrodes for in

(i) enzymes;

 

 

 

 

 

 

 

 

vitro and in vivo investigation was experimented, for the

(ii)

antibodies;

 

 

 

 

 

 

 

 

first time,

in

1996 when

the Ajayan’s

group

construc-

(iii)

nucleic acid;

 

 

 

 

 

 

 

 

ted

a nanotube-electrode

for neurotransmitters

involving

(iv)

receptors;

 

 

 

 

 

 

 

 

dopamine, using bromophorm as binder.198 The voltamo-

(v)

intact cells.

 

 

 

 

grame profile, corresponding to the oxidation of active molecules, such dopamine, has demonstrated the superiority of the CNT electrode, versus the untreated one. This new attainment of the electrode has been attributed to the carbon nanotubes size, as well as to their electronic structure combined with their topological parameters.

Moreover, in 1998, the foremost demonstration of the CNTs potential for protein immobilization202 has proven that small proteins are not only immobilised at the nanotube surface, but they can also be readily placed within the interior cavity of the opened nanotube. This assertion

J. Nanosci. Nanotechnol. 6, 1883–1904, 2006

1897

Polizu et al.

 

 

 

 

Applications of Carbon Nanotubes-Based Biomaterials in Biomedical Nanotechnology

 

 

reveals the capability of SWNTs to act as a benign host

involves the use of purely electrical transducers in pro-

for the selective encapsulation of proteins inside the tube,

teomic applications with the aim to detect different pro-

which is a real potential for biosensors. At the same

teins without labelling them.

time, Gao has researched the possibility of deposing DNA

On the other hand, the nanotubes compound with a

molecules on robust nanotubes, thus proving the nanotubes

polymer resulting in the production of composite material

capacity to recognize different biomolecules as a function

for the construction of electrochemiluminescence-sensing

of their diameter and helicity.203 These progresses con-

device.211 Adapted for immobilization of streptavidin, they

tributed to a better comprehension of the interactions bet-

are attractive for the realization of a nanotube based quan-

ween nanotubes and molecular species, in addition to their

titative biosensor, capable for wide range measurements

sensing mechanisms. Furthermore, a relationship between

of biological analytes, with application in areas of med-

electronic properties and the absorption of gas molecules

ical diagnoses, drug discovery, etc. Moreover, the con-

was formulated.204

 

 

 

 

 

struction of a 3D electrode for a stable, very sensitive

Theoretical calculations indicate that the molecule abs-

and high selective glucose sensor was realised by using

orption on the surface or inside the nanotube bundle is

aligned CNT coated with conducting polymer favouring

stronger than that on an individual tube. In addition, the

enzymes accessibility, thus increasing efficiency.172 The

impressive properties of nanotubes, such as nanometer

use of CNTs facilitates the development of single enz-

size, large surface area, and chirality—dependent on elec-

yme biosensors, with activity toward thiocoline, without

trical conductivity, have been exploited for building the

the use of mediating redox species. A surface modifica-

nano-arrays, functioning as biosensors or double layer

tion of MWNT electrode makes possible immobilization

capacitor, with higher resolution. Hence, the use MWNT

of the enzyme213 in a simple construction which per-

arrays as an immobilization matrix for the development of

forms with good precision and excellent limit of detec-

amperometric biosensor have been reported by Sotiropoulu

tion whilst ensuring good stability and reproducibility.

and Chaniotakis.10 Using oxidation for opening and func-

Therefore, significant advancements are attempted in clin-

tionalizing of the nanotube array leads to an efficient

ical medicine, enabling direct electrical detection of bio-

immobilization of glucose oxidaze enzyme. In this system,

logical and chemical agents. In fact the preparation of

a platinum substrate acts as direct transduction platform

polymeric nanocomposite from nanotubes and PVA214 and

for signal monitoring, whereas the nanotubes play a dual

CNTs/nickel hexacyanoferrate nanocomposite215 resulted

 

Delivered by Publishing Technology to: University of Waterloo

role, as an immobilization matrice as well as a mediator.

in significantly improved electrical conductivity and elec-

 

 

 

IP: 200.59.59.16 On: Tue, 20 Oct 2015 13:16:49

The reported results are very promisingCopyright:for the thirdAmericangener-

tro catalytic activity resulting in good electrochemical per-

Scientific Publishers

ation of biosensors. The SWNT capability to act as a build-

formance for glucose detection when used as an electrode.

ing block for nanobiosensors, dedicated to the sub-cellular

Moreover, using the bio-composite principle, a CNT epoxy

kinetic studies, has been investigated by Guisepi-Elie and

composite biosensor was built which offers an excellent

collaborators.205 It seems that the nanotubes can perform

sensitivity and stable electrochemical properties combined

as a benign host enables to trap and support biological

with a reliable calibration profile.216

molecules while the acidic sites present at the surface

5.5.2. CNTs Flow Sensors

enhance molecule binding. This resulting proximity facili-

tates the redox process of proteins and enzymes from a

The excellent sensing capacity of nanotubes was extended

kinetic and energetic point

of view. Thus, coupling the

to the flow conditions resulting in systems for flow envi-

SWNTs with redox active enzymes favours nanobiosen-

ronment. Gosh and his collaborators reported the experi-

sors development, i.e., the

evolution

of

glucose biosen-

mental observation of the voltage generated by the flow of

sors.206–210

This functional

enrichment,

resulting from

a polar liquid over SWNT bundles. The magnitude of volt-

nanoscale

surface modification

of implantable

devices,

age induced along the nanotube significantly depends on

triggers many surface interactions with biological host tis-

the ionic strength and polar nature of the liquid.217 A high

sue, in order to either evade the host’s immune system or

sensitivity along with a fast response time was detected at

to successfully engage it in a mutual reaction.211

 

 

low velocities, following the direction of the current ver-

Noncovalent functionalization

of SWNTs212

has also

sus the fluid flow. These results demonstrate the ability of

been considered for the development

of

highly

specific

nanotubes to act as flow sensors for small volumes, in a

electronic

biomolecule detectors,

with

a

selective recog-

flowing liquid environment, which is ideal for biomedical

nition, enable to target proteins

by the

conjugation of

applications.

their specific receptors.195 These biosensors easily work in

 

the clinical detection of biomolecules, such as antibodies,

5.5.3. CNTs Nanosensors and Probes

associated with human autoimmune diseases. Two princi-

 

pal applications have been found for this array system: the

Carbon nanotubes are considered the primarily building

first brings into play the selective detection of proteins in

materials for nanosensors because they function both as

solution and considers the detecting serum protein after a

sensor elements and as electrical contacts.173 An innovative,

vaccination or a therapeutic intervention. The second one

alternative method for the fabrication of nanowire sensor

J. Nanosci. Nanotechnol. 6, 1883–1904, 2006

Applications of Carbon Nanotubes-Based Biomaterials in Biomedical Nanotechnology

Polizu et al.

 

 

arrays was developed using an electrodeposition technique.

Topics regarding structural and mechanical character-

The main advantages are related to the effectiveness of this

istics, fabrication methods along with tip characteristics,

process to produce individually or addressable nanowire

resolution as well as functional imaging, are featured. The

sensor arrays with multi-chemical sensing capabilities,

tips obtained by different methods,227 provide images of

thus stimulating the evolution of carbon nanotube based

biomolecules or bio-assemblies, with a very high lateral

nanosensors.218 Such versed sensors are capable of fitting

resolution owing to nanotubes robustness.222 New triple-

inside single cells thus capturing information related to the

probe atomic force microscope, consisting in an AFM sys-

concentration of proteins in living cells during the body’s

tem coupled to carbon nanotube nanotweezers, was tested

normal operation; they play a major role in the development

for the first time with the aim to measure the electric

of miniaturized, implantable devices for full-time detec-

properties of a tri-terminal single DNA molecule device.228

tion of medical problems. Hence, the construction of nan-

Hence, the operation of a single DNA molecule as a

otube based probes offers new possibilities for the sensitive

three-terminal device has been demonstrated, leading to

detection of single particles and single molecules.219 The

new opportunities for DNA electronics. Moreover, cur-

SWNTs are very hopeful for conducting probe techniques

rently works demonstrated that changes in electronic char-

as AFM or STM, endowed with high lateral resolution,

acteristics of carbon nanotube FET can be correlated with

high aspect ratio and good resistance. Through function-

DNA detection, demonstrating that DNA adosorption and

alization, the nanotube becomes an ideal tip for biologi-

hybridization were selective for nanotubes.229 This design,

cal molecule probes220 221 and opens up the possibility of

with certain modifications, could serve as nanosensor for

inserting a nanoscale electrode into the small pore struc-

discrimination of DNA in a milliliter of blood.

 

ture. These devices have the capacity to measure the length

5.5.4. CNTs-FET Devices

 

dependence of electrical transport.

222

 

 

 

 

Interfacing nanotechnology with biology enables the

Field Effect Transistors (FETs) have been fabricated by

integration of carbon into highly aligned and water stable

using semi conducting single wall nanotubes. Their exten-

process resulting in electrically-conductive probes.223 With

sive study confirmed that they are extremely sensitive to

several hundreds microns in length, the CNT probes have

the chemical or biological environment (oxygen) surround-

the ability to easily penetrate the cell membrane of epithe-

ing them.174 The capacity of proteins to crystallise in a

Deliv

 

ed by Publishing Te hnology to: University of Waterloo

favours the

lial cells. Such local probes operate in a manner which

helical configuration on the nanotube surface104

 

IP: 200.59.59.16 On: Tue, 20 Oct 2015 13:16:49

 

preserves cells viability; this is a new promising technique

topological compatibility between nanotubes and confor-

 

 

Copyright: American Scientific Publishers

 

for nanoassembly of nano-devices and nano-tools. More-

mation of organic products, such as proteins. On the other

over, new instruments for performing cell-level surgical

hand, the carboxylic open ends of nanotubes, possessing

operation has been performed by using AFM and fabri-

an important hydrophilic behaviour, are not attractive for

cated probes shaped as ultrathin needles.224 This technique

hydrophobic proteins; they thus permit a specific reaction

enables the extended of AFM principle to analyses and

with analyte, leading to its identification.219

 

surgery of living cells. In fact the needle enables to pen-

A new technique for the electronic detection of proteins

etrate the cell membrane and could be easily insert into

was recently experimented using CNTs as a conducting

a nucleus with highly accurate positioning. Furthermore,

channel. Taking advantage of the capacity of biotin-strep-

recent theoretical studies demonstrated the possibility to

tavidin to bind to CNTs, the authors produced a specific

obtain the arrangements as DNA-CNT arrays which could

architecture that uses the nanotube field effect transducer

perform as functioning device.225 This complex system can

and polymer functionalization to obtain a supramolecular

be used as an electronic switch or as device for DNA

assembly.45 The application of a conducting polymer coat-

sequencing.

 

 

ing leads to the conversion of nanotube from p- to n-type

Announcing a promising function for CNT as neuron-

conductor, thus preventing non-specific attachment of pro-

probes, the recent results reveal the CNTs capacity to offer

teins. However, the coating with a hydrophilic polymer

a high spatial resolution required for probing neurons.15

results in a reduction of the affinity of nanotube for pro-

Endowed with high electrical conductance, the small and

teins. Such modifications enhance the activity of a minia-

flexible nanotube enables the

detection of the electri-

turized device, acting as a rapid sensor within individually

cal signal from neuron to neuron. Since the concept of

detect proteins or virus.

 

nanotube bio-nanoprobe has been proven, several studies

The recent works reported a selective reaction path-

have been performed in order to evaluate the detection

way of SWNTs, in which chemical functionalization is

and discrimination capacities of CNT probes towards pat-

controlled by the difference in the nanotube’s electronic

terned samples, using molecular interactions and forces

structure.220 The authors anticipate the extension of this

in bimolecular interactions.222 Thus, the use of nanotubes

concept to cell-based electronic sensing devices for the

as probes has gained great interest in the recent years. A

measurement of electronic responses to living systems,

review paper covering the most important aspects related

with in vivo applications. For instance, the construction of

to this application has been presented.226

a complex architecture coupling SWNT to peptide nucleic

1898

J. Nanosci. Nanotechnol. 6, 1883–1904, 2006

J. Nanosci. Nanotechnol. 6, 1883–1904, 2006

Polizu et al.

Applications of Carbon Nanotubes-Based Biomaterials in Biomedical Nanotechnology

 

 

acid (PNA) was performed.221 This structure intermedi-

of exposure. Functionalized nanotubes are tested for new

ates the attachment to DNA, by hybridization at room

applications in cell immobilization and transport meas-

temperature. Moreover, the incorporation of SWNTs into

urement232 able to ensure biological recognition.

larger devices by interfacing nanotube ends with PAN

5.5.7. CNTs Nanopipettes

enables the creation of highly selective nanotube sensors,

offering a new approach for complex devices, with selec-

The nanopipettes, as new shaping of nanotubes, are based

tive recognition of target proteins in conjugation with their

on a new morphological manifestation of carbon nano-

specific receptors.

 

 

structure, characterised by a hollow conical structure.

 

 

5.5.5. CNTs-Cathode for Imaging X-ray Radiation

This 1–3 nm hollowness remains constant throughout

the length of the structure,234 while the shape grow up,

 

 

The high performance CNT-based field emission cathode

thanks to the simultaneous growth of nanotubes during

for the design of X-ray tubes has been reported230 by using

the chemical vapour deposition process, with the atypi-

CNT film with optimized morphology. This device read-

cal composition for gas phase. These whiskers with some

ily produces both continuous and pulsed X-rays in a pro-

minor faceting on the surface have a pointed tip in the

grammable wave form and with a finite repetition rate.

shape of pipette and the base at submicron size. These

The tubes are constructed using purified SWNT bundles

new carbon nanotube pipettes could be ideal candidates

created by laser ablation; they produce focused electron

for simultaneous drug delivery and in vivo detection of

beams with small energy spread which is potentially used

neurotransmitters.234

as X-ray energy tubes, for high resolution imaging with

 

ultrafine focal spots. This CNT cathode X-ray technology

5.5.8. CNTs Components for Medical Nanorobots

can potentially lead to portable miniature X-ray sources

Nanorobotics is concerned with the interaction between

for specific medical

applications. Recent works,231 pre-

sented the development of a dynamic radiography system

atomicand molecular-sized objects and mainly deals with

their controlled manipulation.235 Nanorobots are nanodevi-

with CNT based microfocus X-ray tube that can generate

ces which, in a futuristic vision, will be used for maintain-

pulsed X-ray radiation with a temporal resolution as short

ing the human body and protecting it against pathogenic

as 50 ns, significantly better than thermionic X-ray tubes.

agents. Having a diameter of about 0.5 to 3 microns,

 

Delivered by Publishing Technology to: Uni ersity of Wa erloo

In spite of some limitations which could be overcome, this

 

 

IP: 200.59.59.16 On: Tue, nanorobots20 Oct 2015could13:16:49be constructed out of parts with dimen-

compact and versatile system is promising for non-invasive

 

 

Copyright: American Sc e tific Publishers

imaging devices for biomedical research, as proven by the

sions in the range of 1 to 100 nanometers. They will allow

doctors to perform direct in vivo surgery on individual

first results.231

 

 

 

human cells;235 the powering of nanorobots can be sup-

5.5.6. CNTs Nanotweezers for Biological Applications

plied by metabolising local glucose and oxygen for energy,

or external energy. In spite of the complexity requirements

 

 

The nanotweezers, a powerful tool for manipulation and

for the design and development of nanorobots, theoretical

performing electric measurements at nanoscale level, fully

and simulation studies are on going. This first step aims

exploit the actuation effect of single nanotubes. Their con-

to explain the role of nanorobot behaviour and to further

struction is based on individually connected, free-standing

propose new approaches and strategies236 for future devel-

carbon nanotubes sitting on two metal terminals separated

opments. In the light of properties and functions presented

by a 50 nm gap.232 The application of a voltage to two

herein, it becomes visible that carbon nanotubes are a very

electrodes causes an electrostatic attraction of the nano-

promising support for some nanorobots components.237

tubes, thus closing the two ends. Such nanoscale elec-

Generally, the objectives of nanomanipulation refer to

tromechanical system was realised, for the first time in

the 3D manoeuvring of chemical compounds for molecule

1999 by Kim and Lieber;233 the electrically conducing and

building which will be further assembled into larger

mechanically robust nanotubes were attached to indepen-

devices. Thus, in living bodies, nanomanipulation involves

dent electrodes made of pulled glass micropipettes. The

nano-scale biological entities such as DNA and proteins

free ends of nanotubes alternatively open and close, while

for the clinical and scientific analysis. This requires mate-

applying a voltage to the electrode. These nanotweez-

rials for the fabrication of nano-devices or components for

ers enable the manipulation of individual nanostructures,

integrated systems, with very specific properties. Indeed,

and their electrical properties can be harnessed in sev-

by manipulating carbon nanotubes at both the atomic and

eral manners.233 One of them finds application in the bio-

molecular scale, the biological assemblies integrating car-

logical field, for manipulations/modifications within a cell.

bon nanotubes are more accessible.235

The construction of dual mechanical/chemical nanotweez-

On the other side, nanorobots could assist the immune

ers is based on the self assembly principle, through bio-

system by finding and disabling unwanted bacteria or

recognition on the molecular level.232 The resulting tubes

viruses. When an invader is identified it can be punc-

have 50 nm in diameter and quite uniform length, with

tured, letting its content spill out and thus ending its

the possibility of being quantitative control by the time

efficiency.238 By following a predetermined search pattern,

1899

Applications of Carbon Nanotubes-Based Biomaterials in Biomedical Nanotechnology

 

 

 

 

Polizu et al.

 

 

the nanorobots can ingest and destroy harmful bacteria

imaging and in perspective, a constitutive element for

they encounter by using mechanical and chemical phago-

nanorobots.221

 

 

 

 

 

 

 

cytosis. Such devices enable to distinguish every cell type

 

 

 

 

 

 

 

 

 

 

 

by checking their surface antigen by

chemotactic

sen-

6. TRENDS FOR THE FUTURE:

 

 

 

sors

 

keyed to specific antigens

target

cells. Nanorobots

 

 

 

 

CHALLENGES AND OPORTUNITIES

 

would even work in the bloodstream where they could nib-

 

 

 

 

 

 

 

 

 

 

 

 

ble away at arterisclerotic deposits, widening the diseased

The

CNTs

contribution to biomaterials

appears to

be

blood vessels.239 240

 

 

 

 

 

 

 

 

 

 

 

 

fascinating

and they are of a

major significance

for

Carbon nanotubes and their nanocomposites offer sup-

the medicine and biomedical applications. However, the

port

 

for

nanoelectromechanical

systems

(NEMS)

and

 

scientists’ preoccupation concerning the potential risk of

microand nano-robots; endowed with high strength and

nanostructures to human health raises an uncertainty. Inter-

chemical inertness they can thus avoid an attack by the

pretation of information regarding the toxicological effects

host’s immune system. Recently, new methods have been

generated by

inhalation and handling of

carbon nano-

developed in order to construct, at the nanometer scale,

tubes suggest that a policy of industrial hygiene measures

building blocks

of carbon nanotubes with

these desired

must be elaborated. Additional confusions relating to the

features. These

3D assemblies,

built

with great accu-

effects of their surface area and geometric parameters are

racy, could be functionalized using biological specimens.

pulling alarm trigger about the potential risks and there-

Indeed, based on controlled nanostructure interactions and

fore, necessitate precise requirements for the use of nano-

complexity, nanoassemblies can posses

 

a

higher density

 

tubes into the body. Therefore, a sensible research able to

and

thus

become better electrical conductors,

faster

cir-

answer the growing concern regarding unintended negative

cuits as with more complex functions and with reduced

impacts would be of a great value for the enormous inter-

power consummation.241 Such sophisticated architectures

est generated by the use of carbon nanotubes in engineered

are in reality quite similar to biological entities with nano-

nano-biomaterials with advanced functions for biomedical

scale

organization. This resemblance facilitates the

sys-

applications.

 

 

 

 

 

 

 

tem’s integration to the living body, resulting in the estab-

 

 

 

 

 

 

 

From

molecular-scale components of

nanoelectronic

lishment of much more natural interactions, thus offering

devices to nanoactuators and nanorobots, the nanotubes

a greater

 

 

 

 

 

 

 

 

control and highDeliveredresolutionbymonitoringPublishingofTechnologythe

to: University of Waterloo

 

 

 

 

 

 

 

 

 

 

 

 

235 240

 

 

will be the support of a revolutionizing class of devices

phenomena, without secondary

IP: 200.59.59.16 On: Tue, 20 Oct 2015 13:16:49

 

 

 

 

 

effects.

 

 

Moreover,

with diagnostic and therapeutic aims. Moreover, the in-

 

 

 

 

 

Copyright: American Scientific Publishers

 

 

 

 

 

 

building a high level programming system for their manip-

progress nanoscale

research enhances nanotechnology’s

ulation is a big challenge since it involves the integration

contribution to medicine and thus new prototype devices

of various components.241

 

 

 

 

 

 

 

 

 

 

 

 

will be able to overcome most of the limits of modern

In fact, the design of CNTs based SPM is currently in

medicine. Theoretical models and experimental research

progress and will play an important role in the advance-

demonstrated

there

bewildering

potential. The chemical

ment

of

nanorobotics.242 Some

representative develop-

inertness of

CNTs

along with

their nanoscale dimen-

ment’s elements are:

 

 

 

 

 

 

 

 

 

 

 

 

sions renders them perfect candidates

for

biological

(i) substrate that serves as nanofixture;

 

 

 

 

 

 

 

 

 

 

and

biotechnological applications.84 85 171

Their intrin-

(ii)

tips, probes, and molecules that serve as grippers or

sic properties enable their bioconjugation for biosensing

end-effectors;

 

 

 

 

 

 

 

 

 

 

 

 

 

 

applications.16 187 188

Moreover, the remarkable combina-

(iii)

 

chemical and physical nanoassembly processes;

 

tion

of

electronic and mechanical

properties

of CNTs

(iv)

primal nanoasssembly operation for insertion;

 

 

makes

them

a potential building

block

of

revolution-

(v)

methods exploiting selfassembly thus eliminating spa-

ary

electronic

devices and nano-electromechanical sys-

tial uncertainty;

 

 

 

 

 

 

 

 

 

 

 

 

 

 

tems with applications in the biological and biomedical

(vi)

adequate hardware for building nanostructure;

 

 

fields.137 144 232 234 240

 

 

 

 

 

(vii)

algorithms and software for sensory interpretation;

As biocompatible support for biological assemblies or

(viii)

motion planning;

 

 

 

 

 

 

 

 

 

 

 

 

nanomechanical part in integrated

systems,

these new

(ix)

SPM driving.

 

 

 

 

 

 

 

 

 

 

 

 

materials become components for implants, artificial org-

 

 

 

 

 

 

 

 

 

 

 

In response, CNTs obviously exert a multiplicity of

ans and other prosthetic devices.153 156 157 They contribute

functions243 in nanoelectronics, and other nanodevices.

to the advancement of medical applications and promote

Even though the fabrication of a complete circuit at

a new approach to nanomedecine, with safer, more effi-

the molecular level remains a challenge, the realisation

cient and ultimately, more powerful tools. Biosensors offer

of CNT based nano electronic devices is presently in

a wide range of new biotechnological enhancements; they

progress and hence, paves the way to nanorobot produc-

are the key to a number of major projects in medical

tion. As presented in a previous section, a complex sys-

technology such as the development of artificial organs

tem has been manufactured using CNT probe tip.189 This

that mimic the function of real organs more accurately.

system is

the precursor of tips

for molecular

resolution

Biosensoring technology, based on carbon nanotubes will

1900

J. Nanosci. Nanotechnol. 6, 1883–1904, 2006

Polizu et al. Applications of Carbon Nanotubes-Based Biomaterials in Biomedical Nanotechnology

be unique due to its high sensitivity, selectivity, stability,

18.

M. S. Dresslhaus, G. Dresselhaus, and R. Saito, Physics of Carbon

size, and mobility.175 176 178 211 212 221

 

 

 

 

 

 

 

 

19.

Nanotubes. Imperial College Press, London (1998).

Device miniaturization and

the

creation of robots for

P. M. Ajayan, T. W. Ebbessen, T. Ichihashi, S. Iijima, K. Tanigaki,

 

and H. Hiura, Nature 362, 522 (1993).

 

 

 

 

 

 

 

 

 

 

 

 

 

nanomedecine will be promoted by new designs and sophi-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

20.

J.-C. Charlier, Acc. Chem. Res. 35, 1063 (2002).

sticated models239 incorporating carbon nanotubes. Func-

21.

P. M. Ajayan,

Chem. Rev. 99, 1787 (1999).

 

 

 

 

 

 

 

 

 

 

 

 

 

tionalized CNTs allow the construction of new devices for

22.

H. W. Zhu, C.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

L. Xu, D. H. Wu, B. Q. Wei, R. Vajtai, and P. M.

the identification of specific binding sites and chemically

23.

Ajayan, Science 296, 884 (2002).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

distinct domains

of

proteins.54 71 These nanotube based

T. W. Odom, J.-L. Huang, P. Kim, and C. Lieber, J. Phys. Chem.

 

B 104, 2794 (2000).

 

 

 

 

 

 

 

 

 

 

 

 

 

devices offer new opportunities for the detection of biolog-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

24.

P. L. McEuen, Phys. World 31 (2000).

 

 

 

 

 

 

 

 

 

 

 

 

 

ical species clinically, as well as important sensing inter-

 

 

 

 

 

 

 

 

 

 

 

 

 

25.

H. Dai, Opportunities and challenges, Surface Science 500, 218

actions with a well defined transfer function.188 228 Many

 

(2002).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

new effects allow the creation of materials and machines

26.

S. Iijima and T. Ichihashi, Nature 363, 603 (1993).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

27.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

A. Casse, S. Fan,

with unique nanoscale properties without the macroscopic

H. Dai, J. Kong, C. Zhou, N. Franklin, T. Tombler,

 

and M. Chapline, J. Phys. Chem. B 103, 11246 (1999).

counterparts.9 Another fascinating application is molecular

 

28.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

M. A. Hamon, H. Hu, P. Bhowmik, S. Niyogi, B. Zhao, M. E. Itkis,

recognition involving both classes of biomolecules, anti-

 

and R. C. Haddon, Chem. Phys. Lett. 347, 8 (2001).

bodies, and nucleotides.203 221 171

 

 

 

 

 

 

 

 

 

 

 

29.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1997).

 

 

 

 

 

 

 

 

 

 

 

 

 

R. S. Smalley, Reviews of Modern Physics 69, 723

We conclude on the marvellous role that carbon nano-

30.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

A. Hirsch, Angew. Chem. Int. Ed. 41, 1853 (2002).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

31.

T. W. Odom,

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

tubes could

 

play

in

the development

of biomaterials in

 

 

J.-L. Huang, P. Kim, and C. M. Limbers, Nature 391,

 

 

62 (1999).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

the

future,

while

emphasizing

on

the

challenges related

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

32.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

J. W. G. Wildöer, L. C. Venema, A. C. Rinzler, R. E. Smalley, and

to their fabrication and biocompatibility. Based on ongo-

 

C. Dekker, Nature 391, 59 (1998).

 

 

 

 

 

 

 

 

 

 

 

 

 

ing progresses, more concretizations are expected in their

33.

 

 

 

 

 

C. T. White, Phys. Rev. Lett. 68,

J. W. Mintmire, B. I. Dunlap, and

formulation at macroscopic level, in sheets, fibers or com-

34.

631 (1992).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

posite forms. Solving this problem will enable to extend

M. Ouyang,

J. L. Huang, and C. Lieber, Acc. Chem. Res. 35, 1018

 

(2002).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

the exploration of the unique properties of nanotubes, con-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

35.

 

Eletskii, Physics-Uspekhi 40, 899 (1997).

 

 

 

 

 

 

 

 

 

 

 

 

 

A. V

 

 

 

 

 

 

 

 

 

 

 

 

 

firmed at the individual level, and will instigate original

36.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

V

N. Popov,

Materials Science and Engeering:

 

 

R: Reports R43,

initiatives in the promotion of new biomaterials.

37.

61 (2004).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

P. M. Ajayan and O. Z. Zhou, in Carbon Nanotubes, Topics Appl.

 

 

 

 

 

 

 

 

 

 

Delivered by Publishing Technology to: University of Waterloo

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Phys., Springer-Verlag, Berlin Heidelberg (2001), Vol. 80, p. 391.

References and Notes

 

IP: 200.59.59.16 On: Tue, 20 Oct 2015 13:16:49

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Copyright: American Scientific Publishers

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

38.

R. M. D. Stevens, N. A. Frederick, B. L. Smith, D. E. Morse, G. D.

1.

 

K. Bogunia-Kubik and M. Sugisaka, BioSystems 65, 123 (2002).

 

Stucky, and P. K. Hansma, Nanotechnology 11, 1 (2001).

 

39.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

97, 3809

 

C. L. Cheung, J. H. Hafner, and C. M. Lieber, PNAS

2.

 

P. Petit and A. Loiseau, C. R. Physique

4, 967 (2003).

 

 

 

(2000).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3.

 

P. M. Ajayan, J.-C. Charlier, and A. G. Rinzler, PNAS 96, 14199

40.

C. V Nguyen, K.-J. Chao, R. M. D. Stevens, L. Delzeit, A. Cassel,

4.

(1999).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

J. Han, and M. Meyyappan, Nanotechnology 12, 363 (2001).

 

E. Bekyarova, Y

Ni, E. B. Malarkey, V

Montana, J. L. McWiliams,

41.

A. G. Rinzler, J. H. Hafner,

P. Nikolaev, L. Lou, S. G.

Kim,

5.

 

R. C. Haddon, and V

Parpura, J. Biomed. Nanotechnol. 1, 3 (2005).

 

D. Tomanek, P. Nordlander, and D. T. Colbert, Science 269, 1550

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1995).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

S. Iijima, Nature 354, 56 (1991).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

6.

 

 

 

 

 

 

 

 

 

 

 

 

42.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

H. W. Kroto, J. R. Heath, S. C O’Brien, R. F. Curl, and R. E.

H. R.

Shea, R. Marte, T. Hertel, T. Schmidt, and Ph. Avouris,

 

 

Smaley, Nature 318, 162 (1985).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Microelectronic Engineering 46, 101 (1999).

 

 

 

 

 

 

 

 

 

 

 

 

 

7.

 

 

 

 

 

 

21, 1166 (2003).

 

 

 

43.

 

 

Grüner, Nano Lett. 3,

 

V L. Colvin, Nature Biotechnol.

 

 

 

 

 

 

A. Star, J.-C. P. Gabriel, K. Bradley, and G.

8.

 

N. Sinha, J.

Ma, and J. T. W. Yeow, J. Nanosci.

Nanotechnol. 6,

 

461 (2003).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

9.

573 (2006).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

44.

S. Banerjee, T. Hemraj-Benny, and S. S. Wong, J. Nanosci. Nano-

 

P. Ball,

 

Nanotechnology 13, 15 (2002).

 

 

 

 

 

 

 

 

 

technol. 5, 841 (2005).

 

 

 

 

 

 

 

 

 

 

 

 

 

10.

 

 

 

 

 

 

 

 

 

 

 

 

Carbon nanotube array-

45.

 

 

 

 

 

J. Phys. Soc. Jap. 62, 1255 (1993).

 

S. Sotiropoulu and N. A. Chaniotakis,

H. Ajiki and T. Ando,

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

46.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

based biosensor, Anal. Bioanal. Chem. 375, 103 (2003).

 

L. Langer, L. Stockman, J. P. Heremans, V

Bayot, C.

H. Olk,

11.

 

S. Sotiropoulu,

V

Gavals, V Vamvakaki, and A.

Chaniotakis,

 

V

Haesendonck, Y Bruynseraede, and J.-P. Issi, J. Mater. Res. 9,

12.

 

Biosensors and Bioelectronics 18, 211 (2003).

 

927 (1994).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Srivastava, J. Nanosci.

47.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

K. Q. Awasthi, A. Srivastava, and O. N.

A. R. Harutyunyan, B. K. Pradhan, G. U. Sumaneskera, E. Yu.

13.

 

Nanotechnol. 5, 1616 (2005).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Korobko, and A. A. Hustnesov, Europ. Cells Mater. 3, 84 (2002).

 

C. Journet, L. Alvarez, V

Micholet,

T. Guillard, M. L. De la

48.

A. Srivastava, O. N. Srivastava, S. Talapatra, R. Vajtai, and

 

 

Chapelle, E. Anglaret, J. L. Sauvajol, S. Lefrant, P. Bernier,

 

M. Ajayan, Nature Mater. 3, 610 (2004).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

D. Laplaze, G. Flamant, and A. Loiseau, Synth. Metals 103, 2488

49.

Y

Lin, X.

Jiang, T. Elkin, K. A.

Shiral

Fernando, L. Gu,

14.

 

(1999).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

S. Taylor, H. Yang, E. Jones, W. Wang, and Y

P. Sun, J. Nanosci.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Nanotechnol. 6, 868 (2006).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

X. Liu, C. Lee, S. Han, C. Li, and C. Zhou, Molecular Nano-

50.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

electronic, in Molecular Nanoelectronics, American Scientific Pub-

 

 

 

 

 

Ebessen, and J. M Gibson, Nature 381,

 

 

M. M. J. Treacy, T. W.

 

 

lisher (2003), Chp.1, p. 1.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

6584 (1996).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

15.

 

J. W. Seo, E. Couteau, P. Umek, K. Hernadi, P. Marcoux, B. Lukic,

51.

O. Lourie, D. M. Cox, and H. D. Wagner, Phys. Rev. Lett. 81, 1638

 

 

Cs. Miko, M. Milas, R. Gaal, and L. Forro, New J. Phys. 5, 120.2

 

(1998).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(2003).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

52.

J.-P.

Salvetat, S. Bhattacharyya, and R. Byron Pipes, J. Nanosci.

16.

 

S. Iijima, Physica B 323, 1 (2002).

 

 

 

 

 

 

 

 

 

 

 

 

Nanotechnol. 6, 1857 (2006).

 

 

 

 

 

 

 

 

 

 

 

 

 

17.

 

 

 

 

 

and R. Saito, Carbon 33, 883

53.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

M. S. Dresslhaus, G. Dresselhaus,

D. H. Roberston, D. W Brenner, and J. W. Mintmire, Phys. Rev. B

 

 

(1995).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

45, 12592 (1992).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

J. Nanosci. Nanotechnol. 6, 1883–1904, 2006

1901

Applications of Carbon Nanotubes-Based Biomaterials in Biomedical Nanotechnology

 

 

 

 

 

 

 

 

Polizu et al.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

54.

M. R. Falvo, G. J. Clary, R. M. Taylor, V Chi, F. P. Brooks, Jr.,

92.

M. Holzinger, O. Vostrowski, A. Hirsch, F. Hennrich, M. Kappes,

 

S. Washburn, and R. Superfine, Nature 389, 582 (1997).

 

 

 

 

 

 

 

 

R. Weiss, and F. Jellen, Angew. Chem. Int. Ed. 40, 4002 (2001).

55.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

215 (2003).

93.

E. T. Mickelson, C. B.

 

H.

D. Srivastava, C. Wei, and K. Cho, Appl. Mech. Rev. 56,

Huffman, A. G. Rinzler, R. E. Smalley, R.

56.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Hauge, and J. L. Margrave, Chem. Phys. Lett. 296, 188 (1998).

H. Hiura, T. W. Ebbesen, J. Fujita, K. Tanigaki, and T. Takada,

 

 

Nature 367, 148 (1994).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

94.

K. F. Kelly, I. W. Chiang,

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

E. T. Mickelson, R. H. Hauge, J. L.

57.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Margrave, X. Wang, G. E. Scuseria, C. Radloff, and N. J. Halas,

E. W. Wong, P. E. Sheehan, C. M. Lieber, Science 277, 197 (1997).

 

58.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Chem. Phys. Lett. 313, 445 (1999).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

B. Vigolo, P. Poulin, M. Lucas, P. Launois, and P. Bernier, Appl.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Phys. Lett. 81, 1210 (2002).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

95.

 

P. J. Boul, J. Liu, E. T. Mickelson,

C. B. Huffman, L. M. Ericson,

59.

 

L. P. Biro, G. I. Mark, and

J. Gyulay, P. A., Mater. Struct. 6, 104

 

I. W. Chiang, K. A. Smith, D. T. Colbert, R. H. Hauge, J. L.

 

(1999).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Margrave, and R. E. Smalley, Chem. Phys. Lett. 310, 367 (1999).

60.

Ph. Avouris, T. Hertel, R. Martel, T. Schimdt, H. R. Shea, and R. E.

96.

S. E. Backer, W. Cai, T. L.

 

 

 

J.

Lasseter, K. P. Weidkamp, and R.

 

Walkup, Appl. Surf. Sci. 141, 201 (1999).

 

 

 

 

 

 

 

 

Hamers, Nano Lett. 2, 1413 (2002).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

61.

Q. Zhao,

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

97.

 

 

 

 

 

 

 

 

 

 

 

 

 

Proc. 737 (2003), Mat. Res. Soc.

Z. Gan, and Q. Zhuang, Electroanalysis 14, 1609 (2002).

S. E. Baker, Mat. Res. Soc. Symp.

62.

S. Niyogi, M. A. Hamon, H. Hu,

B. Zhao, P. Bhowmik, R. Sen,

 

 

Proc. 737,

F.4.6.1 (2003).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

M. E. Itkis, and R. C. Haddon, Acc. Chem. Res. 35, 1105 (2002).

98.

A. Kumar, P. K. Jena, S. Behera, R. F. Lockey, and S. Mohapatra,

63.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

J. Biomed. Nanotechnol. 1, 392 (2005).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

R. C. Haddon, Science 261, 1545 (1993).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

64.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

99.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

A. Hirsch, Angew. Chem. Int. Ed. 32, 1138 (1993).

 

 

 

 

 

 

 

E. T. Mickelson, I. W. Chiang, J. L. Zimmerman, P. J. Boul,

65.

E. Joselevich, Chem. Phys. Chem. 5, 619 (2004).

 

 

 

 

 

 

 

 

J. Lozano, J. Liu, R. E. Smalley, R. H. Hauge, and J. L. Margrave,

66.

M. A, Hamon,

 

 

H. Hui, P. Bhowmik, H. M. E.

 

Itkis, and R. C.

 

J. Phys. Chem. B 103, 4318 (1999).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Haddon, Appl. Phys. A 74, 333 (2002).

 

 

 

 

 

 

 

100.

 

V

N. Khabashesku, W. E. Billups,

and J. L. Margrave, Acc. Chem.

67.

S. Peng and K. Cho, Nanotechnology 11, 57 (2000).

 

 

 

 

 

 

 

101.

Res. 35, 1087 (2002).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

68.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

T.

 

W.

Ebbesen, and

J. C. Charlier, Acc. Chem. Res. 35, 1063 (2002).

 

 

 

 

 

 

 

C.

Richard, F. Balavoine, P. Schultz,

 

69.

M. A. Hamon,

 

J. Chen, H. Hu, Y

 

Chen, M. E.

Itkis, A. M. Rao,

 

C. Mioskowski, Science 300, 775 (2003).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

P. C. Eklund, and R. C. Haddon, Adv. Mater. 11 (1999).

 

 

 

 

 

 

 

102.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Vigolo, A. Pénicaud, C. Coulon, C. Sauder, R. Pailler, C. Journet,

70.

Y Chen, R. C. Haddon, S. Fang, A. M. Rao, P. C. Eklund, W. H.

 

P. Bernier, and P. Poulin, Science 290, 1331 (2000).

 

 

 

 

 

 

 

 

 

 

Lee, E. C. Dickey, E. A. Grulke, J. C. Pendergrass, A. Chavan,

103.

F. Balavoine, P. Schultz,

C. Richard, V

 

Mallouh,

T. W. Ebessen,

 

B. E. Haley, and R. E. Smalley, J. Mat. Res. 13, 2423 (1998).

 

and C. Mioskowski, Angew. Chem. Int. Ed. 38, 1912 (1999).

71.

Y P. Sun, K. Fu, Y Lin, and W.

 

 

1096

104.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Soc.

Huang, Acc. Chem. Res. 35,

R. J. Chen, Y Zhang, D. Wang, and H. Dai, J. Am. Chem.

72.

(2002).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

105.

123, 3838 (2001).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

J. J. Davis, K. S. Coleman, C. B. Bagshaw, and

E. Unger, A. Graham, F. Kreupl, M. Liebau, and W. Hoenlein, Curr.

B. R. Azamian,

73.

Appl. Phys. 2, 107 (2002).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

106.

M. L. H. Green, J. Am. Chem. Soc. 124, 12664 (2002).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Y

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

H. Miyagawa, M. Misra, and A. K. Mohanty, J. Nanosci.

Xu, L. Yang, P. He, and Y Fang, J. Biomed. Nanotechnology 1,

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Delivered by Publishing Technology to: University of Waterloo

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Nanotechnol. 5, 1593 (2005).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

202 (2005).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

74.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

IP: 200.59.59.16 On: Tue, 20

Oct 2015

13:16:49

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

F. Pompeo and D. E. Resasco, Nano Lett. 2, 369 (2002).

 

 

 

 

 

 

 

107.

A. G. Rinzler, J. Liu, P. Nikolaev, C. B. Huffman, F. J.

75.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Copyright:

American Scientific Publishers

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

G. Pastorin, K. Kostarelos, M. Prato, and A. Bianco, J. Miomed.

 

Rodriguez-Macias, P. J. Boul, A. H. Lu, D. Heymann, D. T. Colbert,

 

Nanotechnol. 1, 133 (2005).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

R. S. Lee, J. E. Fischer, A. M. Rao, P. C. Eklund, and R. E. Smalley,

76.

J. L. Stevens, A. Y

 

Huang, H. Peng, I. W. Chiang,

V N.

 

Appl. Phys. A 67, 29 (1998).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Khabashesku, and J. L. Margrave, Nano Lett. 3, 331 (2003).

 

 

 

 

 

 

 

108.

L. Thien-Nga, K. Hernadi,

E. Ljubovic, S. Garaj, and L. Forro,

77.

J. L. Bahr, J. Yang,

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

R. E.

 

Nano Lett. 2, 1349 (2002).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

D. V Kosynkin, M. J. Bronikovski,

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Smaley, and J. M. Tour, J. Am. Chem. Soc. 123, 6536 (2001).

109.

 

 

 

 

 

 

 

 

 

A.

Graff,

 

T.

Pichler,

 

B.

Bendjemil, E. Borowiak-Palen,

 

 

78.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

M. Guerioune, J. Fink, and M. Knupfer, Appl. Phys. A 78, 311

A. Star, Y Liu, K. Grant, L. Ridvan, J. F. Stoddart, D. W.

 

 

Steuerman, M. R. Diehl, A. Boukai, and J. R. Heath, Macro-

 

(2004).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

79.

molecules 36, 553 (2003).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

110.

J.-M. Bonard, T. Stora, J.-P. Salvetat,

F.

Maier, T.

Stöckli,

 

 

 

 

 

 

 

 

C. Duschl, L. Foro, W. A. de Heer, and A. Châtelain, Adv. Mat. 9,

S. S. Wong, S. S. Wong, E. Joselevich, A. T. Woolley, C. L.

 

 

Cheung, and C. M. Lieber, Nature 394, 52 (1998).

 

 

 

 

 

 

 

 

827 (1997).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

80.

 

 

 

Am. Chem. Soc.

111.

M. A. Hamon, J. Chen, H. Hu, A. M. Rao, P. C. Eklund, and R. C.

S. S Wong, J. D. Harper, and P. T. Lansbury, Jr., J.

81.

120, 603 (1998).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

112.

Haddon, Adv. Mat. 11, 834 (1999).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

M. T. Martinez, M. A. Callejas, A. M. Benito, M. Cochet, T. Seeger,

N. R. Wilson, D. H. Cobden, and J. V Macpherson, J. Phys. Chem.

 

B 106, 13102 (2002).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

A. Anson, J. Schreiber, C. Gordon, C. Marhic, O. Chauvet, and

82.

 

C. Dwyer, Martin

Guthold, M. Falvo, S. Washburn, R. Superfine,

 

W. K. Maser, Nanotechnology 14, 691 (2003).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

and D. Erie, Nanotechnology 13, 601 (2002).

 

 

 

 

 

 

 

113.

J. Wei, L. Ci,

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

B. Jiang, Y Li, X. Zhang, H. Zhu, C. Xu, and D. Wu,

83.

R. J. Chen,

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

J. Mater. Chem. 13, 1340 (2003).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Y Zhang, D. Wang, and H. Dai, J. Am. Chem. Soc.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

123, 3838 (2001).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

114.

 

S. R. C. Vivekchand and A.

Govindaraj, Proc. Indian Acad. Sci.

84.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(Chem. Sci.) 115, 509 (2003).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

D. Pantarotto, J.-P. Briand, M. Prato, and A. Bianco, Chem. Comm.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1, 16 (2004).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

115.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

H. Murakami and N. Nakashima, J. Nanosci. Nanotechnol. 6, 16

85.

D. Pantarotto, C. D. Partidos, J. Hoebeke, F. Brown, E. Kramer,

116.

(2006).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

J.-P. Briand, S. Muller, M. Prato, and A. Bianco, Chem. Biol. 10,

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

A. Star, D. W. Steuerman, J. R. Heath, and J. F. Stoddart,

86.

961 (2003).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

117.

Angew. Chem. Int. Ed. 41, 2508 (2002).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Rao, B. C. Satishkumar, A. Govindaraj, and M. Nath,

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

C. N. R.

O.-K. Kim, J. Je, J. W. Baldwin, S. Kooi, P. E. Pehrsson, and L. J.

 

Chem. Phys. Chem. 2, 78 (2001).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Buckley, J. Am. Chem. Soc. 125, 4426 (2003).

 

 

 

 

 

 

 

 

 

87.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

118.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Huffman, Y

 

Wang,

B. Ni and S. B. Sinnot, Phys. Rev. B 61, R16343 (2000).

 

 

 

 

 

 

 

M. J. O’Connell, P. Boul, L. M. Ericson, C.

88.

A. Garg and S. B. Sinnott, Chem. Phys. Lett. 295, 273 (1998).

 

E. Haroz, C. Kuper, J. Tour, K. D. Ausman, and R. E. Smalley,

89.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Chem. Phys. Lett. 342, 265 (2001).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

B. R. Azamian, K. S. Coleman, J. J. Davis, N. Hanson, and M. L.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

H. Green, Chem. Comm. 4, 366 (2002).

 

 

 

 

 

 

 

119.

 

 

 

 

 

Li, and H. Dai, Nano Lett.

 

 

 

 

 

 

 

 

M. Shim, N. W. S. Kam, R. J. Chen, Y

90.

J. L. Bahr and J. M. Tour, J. Mater. Chem. 12, 1952 (2002).

 

 

 

 

 

 

 

120.

2, 285 (2002).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

91.

J. Chen, M. A. Hamon, H.

 

 

 

 

 

 

 

 

Eklund,

 

 

Jr., in Nanomedecine. Biocompatibility, Landes Bio-

Hu, Y

Chen, A. M. Rao, P. C.

R. A Freitas,

 

and R. C. Haddon, Science 282, 95 (1998).

 

 

 

 

 

 

 

 

science, Austin Texas (2003), Vol. 2A, p. 7.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1902

J. Nanosci. Nanotechnol. 6, 1883–1904, 2006